981-1255 .ldreskrift - MSD

Referenser och litteraturlistaAddario. Development considerations in the concept of affective illnesses. J Clin Psychiatry 1985;46: 46-53.Alexopoulos et al. Clinically defined vascular depression. Am J Psychiatry 1997; 154: 562-5.Andersen et al. Citalopram for post-stroke pathological crying. Lancet 1993; 342: 837-9.Benkert et al. An overview of the clinical efficay of mirtazapine. Hum Psychopharmacol 2002; 17(suppl 1) 23-6.Bouman et al. Incidence of SSRI induced hyponatremia due to inappropriate antidiuretic (SIADH)secretion in the elderly. Int J Geriatr Psychiatry 1998;13:12-5.Brodaty et al. Age and depression. J Affect Disord 1991; 23: 137-49.Burns et al. Assessment Scales in Old Age Psychiatry, Martin Dunitz Ltd, London 1999. ISBN 1-85317-778-4.Cole et al. Prognosis of depression in elderly community and primary care populations: a systematicreview and meta-analysis. Am J Psychiatry 1999; 156: 1182-9.DUAG (Danish University Antidepressant Group). Citalopram : Clinical effect profile in comparisonwith clomipramine. Psychopharmacology 1986; 90: 131-8.DUAG (Danish University Antidepressant Group). Paroxetine: A selective SSRI showing bettertolerance but weaker antidepressant effect than clomipramine. J Affect Disord 1990; 18: 288-99.Fastbom. Äldre och läkemedel. Liber AB, Stockholm 2001. ISBN 91-47-05066-7.Foster et al. Lithium in the elderly: A review with special focus on the use of intra-erytrocyte levein detecting serious impeding neurotoxicity. Int J Geriatr Psychiatry 1990; 5: 1-7.Green et al. Risk factors for depression in elderly people. Acta Psychiatr Scand 1992; 86: 213-7.Hirschfeld. The use of mirtazapine in difficult-to-treat populations. Hum Psychopharmacol2002;17(suppl. 1): S33-S36.Kat et al. Efficacy and tolerability of mirtazapine used by elderly depressed patients in TheNetherlands. 11 th ENCP Congres, Paris 1998.Katona, Livingstone. Comorbid depression in older people. Martin Dunitz Ltd, London 1997.ISBN 1-85317-618-4.Klysner et al. The effectiveness of citalopram in the prevention of depression recurrence in elderlypatients. APA Chicago, 2000.Lundmark et al. Serum concentrations of fluoxetine in the clinical setting. Therapeutic DrugMonitoring 2001; 139-47.Mallon. Insomnia. Prevalence, longitudinal course and health consequences. Uppsala Universitet2000. ISBN 91-554-4835-6.Menting et al. SSRIs in the treatment of elderly depressed patients: Qualitative analysis of the literatureon their efficacy and side-effects. Int Clin Psychopharmacol 1996; 11: 165-75.Mittman et al. The efficacy, safety and tolerability of antidepressants in late life: a meta-analysis. JAffect Disord 1997; 46: 191-217.40